<VariationArchive VariationID="17237" VariationName="NM_000089.4(COL1A2):c.487-4_501del" VariationType="Deletion" Accession="VCV000017237" Version="3" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="32276" VariationID="17237">
      <GeneList>
        <Gene Symbol="COL1A2" FullName="collagen type I alpha 2 chain" GeneID="1278" HGNC_ID="HGNC:2198" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="94394895" stop="94431227" display_start="94394895" display_stop="94431227" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="94023872" stop="94060543" display_start="94023872" display_stop="94060543" Strand="+" />
          </Location>
          <OMIM>120160</OMIM>
          <Haploinsufficiency last_evaluated="2012-10-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A2">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-10-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL1A2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000089.4(COL1A2):c.487-4_501del</Name>
      <CanonicalSPDI>NC_000007.14:94405664:TTTCTAAGGGTGCTCGTGGTTTC:TTTC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="94405665" stop="94405683" display_start="94405665" display_stop="94405683" variantLength="19" positionVCF="94405664" referenceAlleleVCF="CTTTCTAAGGGTGCTCGTGG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="94034977" stop="94034995" display_start="94034977" display_stop="94034995" variantLength="19" positionVCF="94034976" referenceAlleleVCF="CTTTCTAAGGGTGCTCGTGG" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>EX11DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.94034981_94034999del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.94034981_94034999del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.94405669_94405687del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.94405669_94405687del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007405.1" sequenceAccession="NG_007405" sequenceVersion="1" change="g.16109_16127del">
            <Expression>NG_007405.1:g.16109_16127del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000089.4" sequenceAccession="NM_000089" sequenceVersion="4" change="c.487-4_501del" MANESelect="true">
            <Expression>NM_000089.4:c.487-4_501del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007405.1" sequenceAccession="NG_007405" sequenceVersion="1" change="g.16108_16126del">
            <Expression>NG_007405.1:g.16108_16126del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_2" sequenceAccession="LRG_2">
            <Expression>LRG_2:g.16109_16127del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="120160.0006" DB="OMIM" />
        <XRef Type="rs" ID="74315146" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000089.4(COL1A2):c.487-4_501del AND Osteogenesis imperfecta, mild" Accession="RCV000018777" Version="30">
        <ClassifiedConditionList TraitSetID="5677">
          <ClassifiedCondition DB="MedGen" ID="C4015953">Osteogenesis imperfecta, mild</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1988-08-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000089.4(COL1A2):c.487-4_501del AND not provided" Accession="RCV002468973" Version="8">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-12-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000089.4(COL1A2):c.487-4_501del AND multiple conditions" Accession="RCV003764608" Version="1">
        <ClassifiedConditionList TraitSetID="67170">
          <ClassifiedCondition DB="MedGen" ID="C0268335">Ehlers-Danlos syndrome, classic type, 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0023931">Osteogenesis imperfecta type I</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-16" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2013-04-04" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17078022</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19344236</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3403536</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7695699</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8218237</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9016532</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="67170" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="54525" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EHLERS-DANLOS SYNDROME, GRAVIS TYPE</ElementValue>
                <XRef Type="MIM" ID="130000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EHLERS-DANLOS SYNDROME, SEVERE CLASSIC TYPE</ElementValue>
                <XRef Type="MIM" ID="130000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ehlers-Danlos syndrome, classic type, 1</ElementValue>
                <XRef ID="MONDO:0019567" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos syndrome, type 1</ElementValue>
                <XRef ID="Ehlers-Danlos+Syndrome+Classic+Type/2484" DB="Genetic Alliance" />
                <XRef ID="83470009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos syndrome, classic type I</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EDS I</ElementValue>
                <XRef Type="MIM" ID="130000" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EDSCL1</ElementValue>
                <XRef Type="MIM" ID="130000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">cEDS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EDS1</ElementValue>
                <XRef Type="MIM" ID="130000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Classic Ehlers-Danlos syndrome (cEDS) is a connective tissue disorder characterized by skin hyperextensibility, atrophic scarring, and generalized joint hypermobility (GJH). The skin is soft and doughy to the touch, and hyperextensible, extending easily and snapping back after release (unlike lax, redundant skin, as in cutis laxa). The skin is fragile, as manifested by splitting of the dermis following relatively minor trauma, especially over pressure points (knees, elbows) and areas prone to trauma (shins, forehead, chin). Wound healing is poor, and stretching of scars after apparently successful primary wound healing is characteristic. Complications of joint hypermobility, such as dislocations of the shoulder, patella, digits, hip, radius, and clavicle, usually resolve spontaneously or are easily managed by the affected individual. Other features include hypotonia with delayed motor development, fatigue and muscle cramps, and easy bruising. Mitral valve prolapse can occur infrequently, but tends to be of little clinical consequence. Aortic root dilatation has been reported, appears to be more common in young individuals, and rarely progresses.</Attribute>
                <XRef ID="NBK1244" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301422</ID>
                <ID Source="BookShelf">NBK1244</ID>
              </Citation>
              <XRef ID="C0268335" DB="MedGen" />
              <XRef ID="MONDO:0019567" DB="MONDO" />
              <XRef Type="MIM" ID="130000" DB="OMIM" />
            </Trait>
            <Trait ID="5697" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OI type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta tarda</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with blue sclerae</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lobstein disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta type I</ElementValue>
                <XRef ID="Osteogenesis+imperfecta+type+1/5454" DB="Genetic Alliance" />
                <XRef ID="385482004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lobstein's Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1</ElementValue>
                <XRef ID="MONDO:0008146" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta with opalescent teeth</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI type 1A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Osteogenesis imperfecta type 1 with dentinogenesis imperfecta</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">OI, TYPE I</ElementValue>
                <XRef Type="MIM" ID="166200" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">OI1</ElementValue>
                <XRef Type="MIM" ID="166200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8694" />
                <XRef ID="8694" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">COL1A1/2 osteogenesis imperfecta (COL1A1/2-OI) is characterized by fractures with minimal or absent trauma, variable dentinogenesis imperfecta (DI), and, in adult years, hearing loss. The clinical features of COL1A1/2-OI represent a continuum ranging from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal dentition, normal stature, and normal life span. Fractures can occur in any bone but are most common in the extremities. DI is characterized by gray or brown teeth that may appear translucent, wear down, and break easily. COL1A1/2-OI has been classified into four types based on clinical presentation and radiographic findings. This classification system can be helpful in providing information about prognosis and management for a given individual. The four more common OI types are now referred to as follows: Classic non-deforming OI with blue sclerae (previously OI type I). Perinatally lethal OI (previously OI type II). Progressively deforming OI (previously OI type III). Common variable OI with normal sclerae (previously OI type IV).</Attribute>
                <XRef ID="NBK1295" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000521190" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260571" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511197" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525779" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512698" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000332445" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561718" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000562498" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301472</ID>
                <ID Source="BookShelf">NBK1295</ID>
              </Citation>
              <Citation Type="general" Abbrev="EMQN, 2012">
                <ID Source="pmc">3234509</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2008">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_OsteogenesisImperfecta.pdf</URL>
                <CitationText>Orphanet Emergency Guidelines: Osteogenesis imperfecta (OI)</CitationText>
              </Citation>
              <XRef ID="216796" DB="Orphanet" />
              <XRef ID="666" DB="Orphanet" />
              <XRef ID="C0023931" DB="MedGen" />
              <XRef ID="MONDO:0008146" DB="MONDO" />
              <XRef Type="MIM" ID="166200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5677" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="12775" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Osteogenesis imperfecta, mild</ElementValue>
              </Name>
              <XRef ID="C4015953" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="39060" SubmissionDate="2011-06-23" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="120160.0006_OSTEOGENESIS IMPERFECTA, MILD" title="COL1A2, EX11DEL_OSTEOGENESIS IMPERFECTA, MILD" />
        <ClinVarAccession Accession="SCV000039060" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1988-08-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a boy with 'atypical' OI and his asymptomatic mother, Kuivaniemi et al. (1988) found deletion of 19 bp at the junction of IVS 10 and exon 11 causing abnormal splicing between exons 10 and 12 and a shortened pro-alpha-2 chain of type I collagen.</Attribute>
              <Citation>
                <ID Source="PubMed">3403536</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A2" />
          </GeneList>
          <Name>COL1A2, EX11DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX11DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="120160.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">OSTEOGENESIS IMPERFECTA, MILD</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5409769" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="GDXSV:253503" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002765193" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Canonical splice site variant in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 3403536)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A2" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="7" alternateAllele="-" referenceAllele="TAAGGGTGCTCGTGGTTTC" start="94034981" stop="94034999" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:668933</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_152_20221221054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8524582" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="4418866|MedGen:C0023931;C0268335" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004569492" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">3403536</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">3403536</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7695699</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">8218237</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19344236</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9016532</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17078022</ID>
          </Citation>
          <Comment>This variant results in the deletion of part of exon 11 (c.487-4_501del) of the COL1A2 gene. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with autosomal dominant osteogenesis imperfecta (PMID: 3403536; Invitae). This variant is also known as a 19-bp deletion that causes in-frame RNA splicing from the last codon of exon 10 to the first codon of exon 12 of the pro-d(I) gene. ClinVar contains an entry for this variant (Variation ID: 17237). Studies have shown that this variant results in skipping of exon 11, but is expected to preserve the integrity of the reading-frame (PMID: 3403536). This variant disrupts the triple helix domain of COL1A2. Glycine residues within the Gly-Xaa-Yaa repeats of the triple helix domain are required for the structure and stability of fibrillar collagens (PMID: 7695699, 8218237, 19344236). In COL1A2, variants affecting these glycine residues are significantly enriched in individuals with disease (PMID: 9016532, 17078022) compared to the general population (ExAC). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL1A2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.94034977_94034995del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023931" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268335" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5409769" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="39060" TraitType="Disease" MappingType="Name" MappingValue="OSTEOGENESIS IMPERFECTA, MILD" MappingRef="Preferred">
        <MedGen CUI="C4015953" Name="Osteogenesis imperfecta, mild" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8524582" TraitType="Disease" MappingType="XRef" MappingValue="C0023931" MappingRef="MedGen">
        <MedGen CUI="C0023931" Name="Osteogenesis imperfecta type I" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8524582" TraitType="Disease" MappingType="XRef" MappingValue="C0268335" MappingRef="MedGen">
        <MedGen CUI="C0268335" Name="Ehlers-Danlos syndrome, classic type, 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

